Skip to main content
Molecular Pharmacology logoLink to Molecular Pharmacology
. 2011 Dec;80(6):1190.

Correction to “Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9”

PMCID: PMC3228528

In the above article [Debebe Z, Ammosova T, Breuer D, Lovejoy DB, Kalinowski DS, Karla PK, Kumar K, Jerebtsova M, Ray P, Kashanchi F, Gordeuk VR, Richardson DR, and Nekhai S (2011) Mol Pharmacol 79:185–196], Pradeep K. Karla should not have been included as an author.

The authors regret this error and apologize for any confusion and inconvenience it may have caused.


Articles from Molecular Pharmacology are provided here courtesy of American Society for Pharmacology and Experimental Therapeutics

RESOURCES